Aptus Capital Advisors, LLC Merck & Co., Inc. Transaction History
Aptus Capital Advisors, LLC
- $11.2 Billion
- Q2 2025
A detailed history of Aptus Capital Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Aptus Capital Advisors, LLC holds 252,675 shares of MRK stock, worth $21.2 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
252,675
Previous 84,329
199.63%
Holding current value
$21.2 Million
Previous $7.57 Million
164.25%
% of portfolio
0.18%
Previous 0.08%
Shares
26 transactions
Others Institutions Holding MRK
# of Institutions
3,849Shares Held
1.96BCall Options Held
29.2MPut Options Held
30M-
Vanguard Group Inc Valley Forge, PA253MShares$21.2 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.4 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$9.94 Billion0.36% of portfolio
-
Wellington Management Group LLP Boston, MA76.9MShares$6.45 Billion1.15% of portfolio
-
Geode Capital Management, LLC Boston, MA59MShares$4.95 Billion0.34% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $213B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...